연구성과로 돌아가기
2023 연구성과별 연구자 정보 (827 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial | Kim, Hyo Myung | Kim, HM | 15 | 교신저자 | Korea Univ Anam Hosp, Dept Ophthalmol, Seoul, South Korea | hyomk@korea.ac.kr; | ||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Kim, Do Young | Kim, DY | 1 | Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Shin, Ho-Jin | Shin, HJ | 2 | Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Min, Chang-Ki | Min, CK | 3 | Seoul St Marys Hosp, Seoul, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Eom, Hyeon-Seok | Eom, HS | 4 | Natl Canc Ctr Korea, Dept Internal Med, Goyang, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Jung, Jongheon | Jung, J | 5 | Natl Canc Ctr, Seoul, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Kim, Kihyun | Kim, K | 6 | Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea | I-6927-2019 | KIM, JIN | ||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Lee, Jae Hoon | Lee, JH | 7 | Gachon Univ, Gil Med Ctr, Seongnam Si, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Yoo, Kwai Han | Yoo, KH | 8 | Gachon Univ, Gil Med Ctr, Seongnam Si, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Lee, Ji Yun | Lee, JY | 9 | Seoul Natl Univ, Div Hematol & Med Oncol, Dept Internal Med, Bundang Hosp,Coll Med, Seongnam, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Byun, Ja Min | Byun, JM | 10 | Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Kim, Sung-Hyun | Kim, SH | 11 | Dong A Univ, Div Hematol Oncol, Dept Internal Med, Coll Med, Busan, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Lee, Ji Hyun | Lee, JH | 12 | Dong A Univ, Coll Med, Busan, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Cho, Hee Jeong | Cho, HJ | 13 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea | ||||||
| Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | Lee, Sang Min | Lee, SM | 14 | Inje Univ, Dept Internal Med, Busan Paik Hosp, Busan, South Korea |
페이지 이동: